CSL Ltd (ASX:CSL)
A$ 278.09 0.46 (0.17%) Market Cap: 134.17 Bil Enterprise Value: 150.72 Bil PE Ratio: 36.59 PB Ratio: 5.23 GF Score: 91/100

CSL Ltd at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 11:30PM GMT
Release Date Price: A$294.5 (-1.60%)
David A. Low
JP Morgan Chase & Co, Research Division - Research Analyst

Good afternoon, everyone. My name is David Low. I cover health care stocks for JPMorgan in Australia. With us this afternoon, I've got Paul Perrault, CEO and MD of CSL, the largest health care company listed in Australia. And just a reminder, after the presentation, we'll be across the whole way in the Georgian room for the breakout. Thanks, Paul.

Paul R. Perreault
CSL Limited - MD, CEO & Executive Director

Thank you, David. Good afternoon, ladies and gentlemen, and thank you for joining us. I'm

happy to be able to provide you with an update on CSL limited and comment on a few points that I think differentiates CSL as an organization and then focus on what we're trying to do to innovate in our space and provide the patients that we serve with our life saving, life extending medicines. So I'll call your attention to the forward-looking statements and

I think you all have seen these legal slides before. I was quite interested in the music that was playing before,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot